The TriNetX Global Health Research Network

The largest global health research network bringing together healthcare organizations, biopharmaceutical companies and contract research organizations.

The TriNetX Global Health Research Network

The largest global health research network bringing together healthcare organizations, biopharmaceutical companies and contract research organizations.

The Fastest Growing Global Health Research Network

Patient Lives

Countries

Clinical Facts

Protocols Analyzed

Trial Opportunities

Healthcare Organizations

  • Increase funding of local research and development teams through increased sponsorship from biopharmaceutical companies
  • Participate in multi-site research with other healthcare organizations, without having to expend precious resources to normalize data to an external standard
  • Allows principal investigators to better understand the target patient population to aid in the development of a study protocol
  • Leverage real-world data and analytics to support grant-based research

Infusing a data-driven approach into the conversation between research institutions and industry provides great efficiencies, but most importantly, it gives our patients the opportunity to potentially participate in clinical trials they otherwise wouldn’t be aware of.

Piotr Sliz

Chief Research Information Officer, Boston Children’s Hospital

Biopharmaceutical Companies

  • Design clinical trial protocols with instant feedback about their feasibility
  • Instantly see a list of sites with patient counts that match the study criteria
  • Gain a path back to the identity of the patient if the site decides to participate in the trial
  • Conduct observational and outcomes research using longitudinal clinical data combined with advanced analytics

Pfizer will use the real-time access to clinical, genomic and oncology data to design clinical trial protocols with greater efficiency. We hope to reduce avoidable amendments by identifying and correcting overly restrictive inclusion and exclusion criteria early in the design process.

Dr. Mohanish Anand

Head of Study Optimization, Pfizer

Contract Research Organizations

  • Equip teams with real-time access to patient populations paired with robust visualizations that will shine in bid defense and live meetings
  • Identify sites with pre-qualified patients. Recommend sites that have patients that sponsors are seeking
  • Choose sites that can quickly generate pre-qualified patient lists upon site selection

TriNetX offers robust query and analytics tools that enable real-time analysis of patient populations, which are helping our customers design better protocols, select the right sites and recruit patients faster.

Dr. Steve Cutler

Chief Executive Officer, ICON